According to Chang, most of these technologies are controlled by relatively small companies that grew out of university research departments; they simply don't have the means to develop the distant Asian market themselves.
張子文表示，其實美國有許多生物技術都掌握在由大學研究室衍生出來的中小型公司中，這些公司對開發遙遠的亞洲市場力有未逮。